$FRLN
Freeline Therapeutics Holdings plc
PRICE
$0.7728 ▲5%
Extented Hours
VOLUME
30,292
DAY RANGE
0.7193 - 0.7699
52 WEEK
0.65 - 15.4
Key Metrics
Market Cap
46.13 M
Beta
1.02
Avg. Volume
103.33 K
Shares Outstanding
60.80 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-16
Next Dividend Date
Company Information
Freeline Therapeutics Holdings PLC operates as a biotechnology company. The Company focuses on developing liver directed gene therapies for bleeding disorders and other debilitating chronic diseases. Freeline Therapeutics serves patients worldwide.
Website: www.freeline.life
HQ: Stevenage Bioscience Catalyst Stevenage, SG1 2FX Hertfordshire
Related News